Showing results for "Science Challenge" in Hygiene & Healthy Living

Gastroesophageal reflux disease (GERD) and Helicobacter pylori (H. pylori) infection are significant gastrointestinal challenges that impact patient quality of life, requiring proper diagnosis and treatment. In this 60-minute, case-based educational activity, multidisciplinary faculty guide clinicians through contemporary diagnostic techniques and evidence-based treatment strategies for both nonerosive and erosive GERD, as well as H. pylori infection.

Hello happiness seekers! I’m Klaudia Mitura, and I’m on a mission to explore the best happiness habits that science has to offer. Like so many others, the pandemic cut me off from family and work — so I decided to use my training as a psychologist to discover what science can tell us about the art of happiness. What I found set me on a path to joy — and now I’m sharing my journey with you. Each month I publish linked episodes where I speak to a leading expert, put their tips to the test, and share my findings (and feelings). From mindfulness to exercise and random acts of kindness, I...

The Rise to the challenge series powered by EIT Health InnoStars gives you first-hand advice if you want to succeed with your start-up. Together with our guests – VCs, start-uppers and global companies, we deliver to your doorstep a road map so you can plan your business journey in the healthcare industry. Our hosts are Ines Matias & Tamas Bekasi, Business Creation Managers at EIT Health InnoStars.

The Private Cancer Physician’s Association (PCPA) is an oncology specialist organisation that aims to make high impact policy change for private practice, education and in delivering to patients the latest treatments and world-class clinical trials. The Cancer Patient Management Podcast series shares the latest updates in innovation for oncology specialists and the ecosystem in which they work to deliver best practice care for their patients. The information in this podcast is current at the time of recording, however we can’t guarantee that it will always apply to you. Be aware that you ...

An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.